Chemical Engineering of the Monoclonal Antibody A7 by Polyethylene Glycol for Targeting Cancer Chemotherapy

Cancer Research

Volumn 51, Issue 16, 1991, Pages 4310-4315

  Kitamura, Kazuya ^a,b   Takahashi, Toshio ^a,b   Yamaguchi, Toshiharu ^a,b   Noguchi, Akinori ^a,b   Noguchi, Akira ^a,b   Takashina, Ken ichiroh ^a,b   Tsurumi, Hiroshi ^a,b   Inagake, Masao ^a,b   Toyokuni, Tatsushi ^a,b   Hakomori, Sen ichiroh ^a,b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b The Biomembrane Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; MACROGOL; MONOCLONAL ANTIBODY A7; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; IMMUNE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIBODIES, MONOCLONAL; DRUG CARRIERS; FEMALE; IMMUNOGLOBULINS, FAB; IODINE RADIOISOTOPES; MICE; MICE, INBRED BALB C; MICE, NUDE; POLYETHYLENE GLYCOLS; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION;

EID: 0025993967     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Miller, R. A., and Levy, R. Response to cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet, 2: 226–230, 1981.
2. Herlyn, D., and Koprowski, H. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc. Natl. Acad. Sci. USA, 79:4761–4765, 1982.
3. Hurwitz, E. Specific and nonspecific macro molecule-drug conjugates for the improvement of cancer chemotherapy. Biopolymer, 22: 557–567, 1983.
4. Shawler, D. L., Bartholomew, R. M., Smith, L. M., and Dillman, R. O. Human immune response to multiple injection of murine monoclonal IgG. J. Immunol., 135:1530–1535, 1985.
5. Tsukada, Y., Ohkawa, K., and Hibi, N. Therapeutic effect of treatment with polyclonal or monoclonal antibodies to a-fetoprotein that have been conjugated to daunomycin via dextran bridge: studies with an α-fetoprotein producing rat hepatoma tumor model. Cancer Res., 47:4293–4295, 1987.
6. Takahashi, T., Yamaguchi, T., Kitamura, K., Suzuyama, H., Honda, M., Yokota, T., Kotanagi, H., Takahashi, M., and Hashimoto, Y. Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma. Cancer (Phila.), 61:881–888, 1988.
7. Honda, M., Takahashi, T., and Yamaguchi, T. Immunoresponse in clinical use of immunoconjugate A7-NCS–with special reference to changes in human anti-mouse antibody level (in Japanese). Biotherapy 4: 844–847, 1990.
8. Abuchowski, A., McCoy, J. R., Palczuk, T. E., and Davis, F. F. Effects of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem., 252:3582–3586, 1977.
9. Davis, S., Park, Y., Abuchowski, A., and Davis, F. F. Hypouricaemic effect of polyethylene glycol modified urate oxidase. Lancet, 2:281–283, 1981.
10. Abuchowski, A., Davis, F. F., and Davis, S. Immunosuppressive properties and circulating life of Achromobacter glutaminase-asparaginase covalently attached to polyethylene glycol in man. Cancer Treat. Res., 65:1077–1081, 1981.
11. Abuchowski, A., Karp, D., and Davis, F. F. Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase. J. Pharmacol. Exp. Ther., 279:352–354, 1981.
12. Matsushima, A., Okada, M., and Inada, Y. Chymotrypsin modified with polyethylene glycol catalyzes peptide synthesis reaction in benzene. FEBS Lett., 175:275–277, 1984.
13. Abuchowski, A., Kazo, G. M., Verhoest, C. R., Es, T. V., Kafkewitz, D., Nucci, M. L., Viau, A. T., and Davis, F. F. Cancer therapy with chemically modified enzymes. Anti-tumor properties of polyethylene glycol-asparaginase conjugates. Cancer Biochem. Biophys., 7:175–186, 1984.
14. Katre, N. V., Knauf, M. J., and Laird, W. J. Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Proc. Natl. Acad. Sci. USA, 84:1487–1491, 1987.
15. Wilkinson, I., Jackson, C. J. C., Lang, G. M., Strevens-Holford, V., and Sehon, A. H. Tolerogenic polyethylene glycol derivatives of xenogeneic monoclonal immunoglobulins. Immunol. Lett., 15:17–22, 1987.
16. Joppich, M., and Luisi, P. L. Peptides flanked by two polymer chains: synthesis of glycyl-L-tryptophylglycine substituted by polyethylene oxide at both the carboxy and the amino end groups. Macromol. Chem., 180: 1381, 1979.
17. Anderson, G. W., Zimmerman, J. E., and Callahan, F. M. The use of esters of N-hydroxysuccinimide in peptide synthesis. J. Am. Chem. Soc., 86:1839– 1842, 1964.
18. Kitamura, K., Takahashi, T., Yamaguchi, T., Yokota, T., Noguchi, A., Amagai, T., and Imanishi, J. Immunochemical characterization of the antigen recognized by the murine monoclonal antibody A7 against human colorectal cancer. Tohoku J. Exp. Med., 157:83–92, 1988.
19. Kotanagi, H., Takahashi, T., Masuko, T., Hashimoto, Y., and Koyama, K. A monoclonal antibody against human colon cancers. Tohoku J. Exp. Med., 148:353–360, 1986.
20. Kitamura, K., Takahashi, T., Yamaguchi, T., Kitai, S., Amagai, T., and Imanishi, J. Monoclonal antibody A7 tumor localization enhancement by its F(ab’)2 fragment to colon carcinoma xenografts in nude mice. Jpn. J. Clin. Oncol., 20:139–144, 1990.
21. Greenwood, F. C., Hunter, W. M., and Glover, J. S. The preparation of I31I-labeled human growth hormone of high specific reactivity. Biochem. J., 89: 114–123, 1963.
22. Laemmli, U. K. Cleavage of structural proteins during the assembly of the band of bacteriophage T4. Nature (Lond.), 227:680–685, 1970.
23. Synder, S. L., and Sobocinski, P. Z. An improved 2,4,6-trinitrobenzenesul-fonic acid method for the determination of amines. Anal. Biochem., 64:284– 288, 1975.
24. Miron, T., and Wilchek, M. A spectrometric assay for soluble and immobilized N-hydroxysuccinimide esters. Anal. Biochem., 126:433–435, 1982.
25. Lobuglio, A. F., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J., and Khazaeli, M. B. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc. Natl. Acad. Sci., USA, 86:4220–4224, 1989.
26. Lisi, P. L., van Es, T., Abuchowski, A., Palczuk, N. C., and Davis, F. F. Polyethylene glycolβ-glucuronidase conjugates as potential therapeutic agents in acid mucopolysaccharidosis. J. Appl. Biochem., 4:19–33, 1982.
27. Andrew, S. M., Pimm, M. V., Perkins, A. C., and Baldwin, R. W. Comparative imaging and biodistribution studies with an anti-CEA monoclonal antibody and its F(ab’) and Fab fragments in mice with colon carcinoma xenografts. Eur. J. Nucl. Med., 12:168–175, 1986.